Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy

Abstract

Real-time monitoring with electronic patient-reported outcomes improved physical well-being (6 and 12 weeks) and self-efficacy (18 weeks) in a patient population predominantly treated with curative intent, without increasing hospital workload.